NCT02938702View on ClinicalTrials.gov

Active Surveillance on Papillary Thyroid Microcarcinoma

Active, not recruitingOBSERVATIONAL
Enrollment

1,211

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2030

Conditions
Thyroid CancerPapillary Thyroid Microcarcinoma
Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02938702 - Active Surveillance on Papillary Thyroid Microcarcinoma | Biotech Hunter | Biotech Hunter